Thromboembolism following removal of femoral venous apheresis catheters in patients with breast cancer

Annals of Oncology

Volumn 15, Issue 9, 2004, Pages 1366-1372

  Saif, M Wasif ^a,c   Leitman, S F ^b   Cusack, G ^a   Horne, M ^b   Freifeld, A ^a   Venzon, D ^b   PremKumar, A ^b   Cowan, K H ^a   Gress, R E ^a   Zujewski, J ^a   Kasten Sportes, C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Apheresis; Breast cancer; Femoral apheresis catheters; Malignancy; Peripheral blood stem cell transplantation; Thromboembolism

Indexed keywords

ACID CITRATE DEXTROSE; ANTICOAGULANT AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; MELPHALAN; METHOTREXATE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; AWARENESS; BREAST CANCER; CANCER PATIENT; CELL SEPARATION; CLINICAL OBSERVATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEVICE REMOVAL; DISEASE ASSOCIATION; DONOR; DOUBLE LUMEN TUBE; DRUG MEGADOSE; ECHOGRAPHY; EXPERIENCE; FEMALE; FEMORAL VEIN; HUMAN; INTRAVENOUS CATHETER; JUGULAR VEIN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHYSICIAN ATTITUDE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCINTIPHLEBOGRAPHY; STEM CELL MOBILIZATION; SYMPTOM; THROMBOEMBOLISM; TIME; VASCULAR ACCESS;

ADOLESCENT; ADULT; AGED; BLOOD COMPONENT REMOVAL; BREAST NEOPLASMS; CATHETERIZATION, PERIPHERAL; FEMALE; FEMORAL VEIN; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOEMBOLISM;

EID: 4644320194     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh347     Document Type: Article

References (32)

1. Haire WD, Lieberman RP, Lund GB et al. Translumbar inferior vena cava catheters: safety and efficacy in peripheral blood stem cell transplantation. Transfusion 1990; 30: 511-515.
2. Conlan MG, Haire WD, Lieberman RP et al. Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation. Bone Marrow Transplant 1991; 7: 235-240.
3. Lazarus HM, Lowder JN, Herzig RH. Occlusion and infection in Broviac catheters during intensive cancer therapy. Cancer 1983; 52: 2342-2348.
4. Lokich JJ, Becker B. Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy. Cancer 1983; 52: 1586-1589.
5. Kaye CG, Smith DR. Complications of central venous cannulation. BMJ 1988; 297: 572-573.
6. Comenzo RL, Vosburgh E, Weintraub LR et al. Collection of mobilized blood progenitor cells for hematopoietic rescue by large-volume leukapheresis. Transfusion 1995; 35: 493-497.
7. Smolowicz AG, Villman K, Tidefelt U. Large-volume apheresis for the harvest of peripheral blood progenitor cells for autologous transplantation. Transfusion 1997; 37: 188-192.
8. Haire WD, Stephens LC, Kotulak GD et al. Double-lumen inferior vena cava catheters for peripheral stem cell apheresis and transplantations. Transfus Sci 1995; 16: 79-84.
9. Haire WD, Edney JA, Landmark JD, Kessinger A. Thrombotic complications of subclavian apheresis catheters in cancer patients: prevention with heparin infusion. J Clin Apheresis 1990; 5: 188-191.
10. Bozzetti F, Scarpa D, Terno G et al. Subclavian venous thrombosis due to indwelling catheters: a prospective study on 52 patients. JPEN J Parenter Enteral Nutr 1983; 7: 560-562.
11. Oliver MJ, Callery SM, Thorpe KE et al. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 2000; 58: 2543-2545.
12. Bambauer R, Mestres P, Pirrung KJ. Frequency, therapy, and prevention of infections associated with large bore catheters. ASAIO J 1992; 38: 96-101.
13. Hahn U, Goldschmidt H, Salwender H et al. Large-bore central venous catheters for the collection of peripheral blood stem cells. J Clin Apheresis 1995; 10: 12-16.
14. Lee JH, Klein HG. Collection and use of circulating hematopoietic progenitor cells. Hematol Oncol Clin North Am 1995; 9: 1-22.
15. Moscow JA, Huang H, Carter C et al. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy. Blood 1999; 94: 52-61.
16. Shariatmadar S, Noto TA. Femoral vascular access for large-volume collection of peripheral blood progenitor cells. J Clin Apheresis 1998; 13: 99-102.
17. Adorno G, Zinno F, Bruno A et al. Femoral catheters: safety and efficacy in peripheral blood stem cell collection. Int J Artif Organs 1999; 22: 710-712.
18. Malatinsky J, Faybik M, Samuel M, Majek M. Surgical, infectious and thromboembolic complications of central venous catheterization. Resuscitation 1983; 10: 271-281.
19. Volkow P, Tellez O, Vazquez C et al. A single, double lumen high-flow catheter for patients undergoing peripheral blood stem cell transplantation. Experience at the National Cancer Institute in Mexico. Bone Marrow Transplant 1997; 20: 779-783.
20. Sack JH, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) 1977; 56: 1-37.
21. Doll DC, Yarbo JW. Vascular toxicity associated with anti-neoplastic agents. Semin Oncol 1992; 19: 580-596.
22. Nicholson GL, Custead SE. Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity. Cancer Res 1983; 45: 331-336.
23. Rogers JS, Murgo AJ, Fontana JA. Chemotherapy for breast cancer decreases plasma protein C and protein S. J Clin Oncol 1988; 6: 276-281.
24. Cantwell BMJ, Carmichael J, Ghani SE. Thromboses and thromboemboli in patients with lymphoma during cytotoxic chemotherapy. BMJ 1988; 297: 179-180.
25. Levine MN, Gent M, Hirsh J. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med 1988; 318: 404-407.
26. Stephens LC, Haire WD, Schmit-Pokorny K et al. Granulocyte macrophage colony stimulating factor: high incidence of apheresis catheter thrombosis during peripheral stem cell collection. Bone Marrow Transplant 1993; 11: 51-54.
27. Love RR, Surawicz TS, Williams EC. Antithrombin III level, fibrinogen level, and platelet count changes with adjuvant tamoxifen therapy. Arch Intern Med 1992; 152: 317-320.
28. Pritchard KI, Peter J, Paul N. Thromboembolic complications related to chemotherapy in a NCI Canada randomized trial of tamoxifen versus tamoxifen plus, chemotherapy in post-menopausal women with axillary node positive receptor positive breast cancer. Proc Am Soc Clin Oncol 1989; 8: 25.
29. Mamby CC, Love RR, Feyzi JM. Protein S and protein C level changes with adjuvant tamoxifen therapy in postmenopausal women. Breast Cancer Res Treat 1994; 30: 311-314.
30. Natazuka T, Kajimoto K, Ogawa R et al. Coagulation abnormalities and thrombotic microangiopathy following bone marrow transplantation from HLA-matched unrelated donors in patients with hematological malignancies. Bone Marrow Transplant 1998; 21: 815-819.
31. Qasim W, Gerrisen B, Veys P. Anticardiolipin antibodies and thromboembolism after BMT. Bone Marrow Transplant 1998; 21: 845-847.
32. Haire WD, Lieberman RP, Lund GB et al. Translumbar inferior vena cava catheters: experience with 58 catheters in peripheral stem cell collection and transplantation. Transfus Sci 1990; 11: 195-200.